Ide Tatsuya | 久留米大学医学部内科学第二

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Peginterferon-alpha-2b plus ribavirin therapy in patients with chronic hepatitis C as assessed by a multi-institutional questionnaire in Japan
Identification of new immunogenic peptides in conserved regions of hepatitis C virus (HCV) 1b with the potentiality to generate cytotoxic T lymphocytes in HCV1b^+ HLA-A24^+ patients
Impaired Filterability of Erythrocytes from Patients with Chronic Hepatitis C and Effects of Eicosapentaenoic Acid on the Filterability
New Epitope Peptides Derived from Hepatitis C Virus (HCV) 2a Which Have the Capacity to Induce Cytotoxic T Lymphocytes in HLA-A2^+ HCV-Infected Patients
Granulocytapheresis (GCAP) for severe alcoholic hepatitis-A preliminary report
Timing of interferon therapy and sources of infection in patients with acute hepatitis C
Clinical course of patients with chronic hepatitis B with viral breakthrough during long-term lamivudine treatment
Adipocytokine involvement in hepatocellular carcinoma after sustained response to interferon for chronic hepatitis C
Systemic Sclerosis Associated with Diabetes Insipidus
Prognostic indicators of breakthrough hepatitis during lamivudine monotherapy for chronic hepatitis B virus infection
Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon
Association of troglitazone-induced liver injury with mutation of the cytochrome P450 2C19 gene
Interferon-γ brings additive anti-viral environment when combined with interferon-α in patients with chronic hepatitis C
Two-year follow-up study after treatment with lamivudine for chronic hepatitis B : seven cases reported
Erythropoietic protoporphyria with fatal liver failure
Lack of detection of hepatitis C virus replicative intermediate in abdominal lymph nodes
Short term and two-step interferon therapy for chronic hepatitis C patients with low HCV RNA levels
Transcription-mediated amplification is more useful in the follow-up of patients with chronic hepatitis B treated with lamivudine
A pilot study of natural interferon γ therapy for chronic hepatitis C
Characteristics of complete responders to interferon among patients with chronic hepatitis C with high serum levels of RNA
Mechanisms of thrombocytopenia induced by interferon therapy for chronic hepatitis B
Phase I clinical study of a peptide vaccination for hepatitis C virus-infected patients with different human leukocyte antigen-class I-A alleles
Second generation amplicor-HCV monitor assay : clinical features and predictors of the response to interferon
Efficacy and safety of double filtration plasmapheresis in combination with interferon therapy for chronic hepatitis C
Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1

もっと見る

スポンサーリンク